Stay up to date

The MRCT Center and Medable convened a multi-stakeholder task force to address ethical and regulatory opportunities and challenges related to Decentralized Clinical Trials (DCTs). Join them on June 20, from 10 - 11 AM ET, for a joint webinar entitled, "Ethical Review of Decentralized Clinical Trials (DCTs): Tools, Resources & Best Practices."  

During the webinar, Barbara Bierer (MRCT Center), Pam Tenaerts (Medable) and Leanne Madre (Medable) will present a framework, recommendations, and tools organized around 3 DCT domains: People, Remote Data Collection, and Data Oversight. Best practices for the ethical review, approval, and conduct of DCTs will be provided.   Clinical trial stakeholders (IRB/ECs, HRPP, sites, sponsors, investigators, and others) to register for the webinar here

Advances in biotechnology have made human gene editing a reality. Progress in the field is gaining momentum
and promises for well-being at a level not previously imagined, emerge. This progress also raises ethical,
legal and social considerations together with valid concerns that the law and ethics are lagging behind.
Moreover, recent reports on abuse of these technologies have triggered disquiet. Gene editing involves
precise additions, deletions and alterations to the genome. Basic science research in gene editing is already
under way in laboratories globally. Clinical applications involving somatic (non-reproductive cells) are in the
early stages and going forward there is great potential for the use of this technology in germline (reproductive)
cells. The first SA Conference on Gene Editing, hosted by the South African Medical Research Council
(SAMRC) together with The Steve Biko Centre for Bioethics and the Wits School of Clinical Medicine will discuss
and debate these issues including what this could mean for us in South Africa and Africa as a whole.